Longboard pharmaceuticals to participate in maxim group 2022 virtual growth conference

San diego, calif., march 22, 2022 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that kevin lind, longboard's president & chief executive officer, will present at the maxim group llc virtual growth conference, taking place march 28–30, 2022.
LBPH Ratings Summary
LBPH Quant Ranking